New effective carrier systems for drug delivery in different dosage applications including oral, topical & parenteral
Multi-million dollar investment augments in-vitro biology capabilities in primary and secondary screening
The new gummy capabilities include a dedicated R&D lab, an automated production line, and bottle packaging solutions
The approval adds to a list of products that Strides has approved in this therapeutic category through the PEPFAR pathway taking the total to 15 products
The investment will help the company meet soaring demand for user-friendly oral dosage form development and manufacturing
With this, the company has secured 511 marketing approvals for its oncology products across 66 countries
The super-resolution optical technology will accelerate discovery in biomedical research and transform in vitro diagnostics
The approval is for acquisition of up to 76.1% equity shares of Suven Pharmaceuticals by Berhyanda Limited
JB Pharma reported 19% decrease in GHG intensity as compared to last year and commenced its journey of Scope 3 emissions
First PARP inhibitor approved in Japan to demonstrate clinically meaningful benefits in combination with a new hormonal agent
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
